Indigo Diabetes NV is working to develop a next-generation continuous glucose monitor (CGM) that would be much simpler and easier to use routinely, potentially making it more useful for a much larger population. It has just raised a €38 million ($44.5 million) series B financing to support that effort.

A medical device company has partnered with a couple of investment firms to tap new technologies and help bring them back to China. Venus Medtech (Hangzhou) Inc. formed a health care investment platform, Ascendum Capital Partners, to invest in new medical devices and technologies around the world, particularly in the cardiovascular and lung disease spaces.

Sudden cardiac arrest (SCA) kills millions of people worldwide each year, triggered by an electrical malfunction in the heart that causes it to unexpectedly stop beating, often without warning. Health care startup Transformative AI Ltd. wants to reduce those deaths. To that end, the company has secured $1.7 million in seed funding for artificial intelligence (AI)-driven software that predicts a patient’s risk of suffering SCA based on subtle physiological changes.

Virtual reality headsets offered a lot of hype around five years ago, but not much in results when it came to medical applications. Medical holograph company Realview Imaging Ltd. has raised a $10 million series C round to enable it to market its first product, Holoscope-i, which offers real-time, 3D holographic images based on any volumetric imaging data during minimally invasive procedures.

Bone fracture repair startup Curvafix Inc. has secured $10.75 million in a series B round led by Sectoral Asset Management with participation from existing investors, including Delta Dental Washington Seed Fund, as well as board members. The company will use the proceeds to complete the RESTORE clinical trial of its U.S. FDA-cleared Curvafix intramedullar rodscrew and to scale up for commercial launch later this year or in 2021.